Atossa Genetics Inc, a clinical-stage biopharmaceutical company headquartered in Seattle, Washington, is dedicated to advancing innovative therapies for breast cancer and infectious diseases. The company's pipeline features key product candidates designed to tackle significant unmet medical needs in oncology, utilizing cutting-edge drug delivery systems and novel formulations. With a strong focus on enhancing patient outcomes through targeted treatments, Atossa is strategically positioned to lead in pharmaceutical innovation within an evolving healthcare landscape.
Click "Analyze" to generate stock analysis
ATOS Price Trend and Signals
ATOS Option Volumes & Open Interests (aggregated)
ATOS Put Call Ratios and IV (aggregated)
ATOS Financials
2025-10-17Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-09Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-08Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-08Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-08Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.